JENNIFER HOGAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FENTON, MI NPI 1093166340

General Payments — all program years on this page

$1,280.48

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $464.27 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $464.2720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $816.2140
2024 $464.2720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104345974 AstraZeneca Pharmaceuticals LP $18.75 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104396967 AstraZeneca Pharmaceuticals LP $16.12 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104614470 AstraZeneca Pharmaceuticals LP $17.12 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105470305 AstraZeneca Pharmaceuticals LP $20.77 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105480561 AstraZeneca Pharmaceuticals LP $22.65 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105710298 AstraZeneca Pharmaceuticals LP $13.56 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114316817 Regeneron Healthcare Solutions, Inc. $16.89 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116361301 GlaxoSmithKline, LLC. $16.55 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116597307 GlaxoSmithKline, LLC. $21.88 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120634880 Baxter Healthcare $50.86 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124753890 Grifols USA, LLC $32.87 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124753892 Grifols USA, LLC $19.24 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126073493 HARMONY BIOSCIENCES LLC $32.85 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134018156 Azurity Pharmaceuticals, Inc. $22.51 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137764421 Takeda Pharmaceuticals U.S.A., Inc. $18.39 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137764423 Takeda Pharmaceuticals U.S.A., Inc. $15.10 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147311874 Mylan Specialty L.P. $23.64 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148156975 Inspire Medical Systems, Inc. $33.36 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149468124 United Therapeutics Corporation $32.88 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151295392 JAZZ PHARMACEUTICALS INC. $18.28 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.